Gender Medicine and Pharmacology, 2nd Edition
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 336
Special Issue Editors
Interests: sex and gender pharmacology; gender medicine; pharmacokinetics; pharmacogenomics; personalized therapy.
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology; sex and gender medicine; pharmacokinetics; pharmacodynamics; pharmacogenomics; personalized therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Sex-based differences in pathophysiology, disease incidence, drug pharmacodynamics/kinetics, response to treatment and related toxicity have been reported. However, underrepresentation of women has been noted in several clinical trials, and data regarding sex are rarely reported in clinical settings. For women, factors such as body size and composition, hormonal variations, metabolism and access to care systems and therapy can strongly influence pharmacological management and treatment outcomes. Differences between the two sexes play an important role in terms of risk factors for the incidence and prevalence of numerous diseases. A gender-based approach should be treated a pivotal tool, optimizing treatment in each patient for each condition.
The Special Issue “Gender medicine and pharmacology” will focus on molecular, cellular and genetic differences in terms of incidence, pathology, physiology and treatment between male, female and genderfluid people. This Special Issue is open for basic to clinical research, or multi-disciplinary approaches.
Dr. Sarah Allegra
Dr. Silvia De Francia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gender medicine
- gender pharmacology
- personalized therapy
- sex
- gender
- therapeutic drug monitoring
- genderfluid
